跳至主要内容
临床试验/CTRI/2023/09/058172
CTRI/2023/09/058172尚未招募2 期

Randomized placebo controlled single blind pilot clinical study to evaluate efficacy of herbal hair mist in hair re-pigmentation and the hair growth in healthy volunteers

Regeron Inc.1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2023年2月10日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
72
试验地点
1
主要终点
Change in hair color from white to original color.

研究概览

简要总结

The purpose of this study is to check ability of prepared herbal formulation in change in hair color of ‘grey hair’ by photographic and questions based response of subject. Formulation application is topical. No any systemic investigation.  Based on above assumption and considering the 20% dropout rate, we proposed to enroll 72 subjects as 36 in each group to get 60 cases (each group 30) at the end of study.

Further each group will be divided in two sub groups based on the age as 20-40 and 41-60 years.

Henceforth final groups for the study;

Group

Age

Treatment

No. of subjects

|I

20-40

Formulation

18

|II

41-60

Formulation

18

|III

20-40

Placebo

18

|IV

41-60

Placebo

18

Frequency of application: twice in a day

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Investigator Blinded

入排标准

年龄范围
40.00 Year(s) 至 60.00 Year(s)(—)
性别
Male

入选标准

  • Presence of gray hairs Person willing to sign an informed consent Person ready to stop application of any hair color or dye 15 days prior to treatment and throughout the treatment.
  • Person with normal hemoglobin count Either male or female.

排除标准

  • Person suffering from any life-threatening disease/disorder.
  • Person not willing to come for follow-up when required.
  • Person who is part of any other clinical trial.
  • Person having any allergy to included ingredients.
  • Other conditions which in opinion of the investigator make subject unsuitable for study.
  • Female with pregnancy.

结局指标

主要结局

Change in hair color from white to original color.

时间窗: 90 days

Safety assessment

时间窗: 90 days

次要结局

  • Stimulation of hair growth(90 days)

研究者

发起方
Regeron Inc.
申办方类型
Pharmaceutical industry-Global

研究点 (1)

Loading locations...

相似试验